"Conditions and Diseases"
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
webmaster
Tuesday, July 11, 2023
Public Health Initiatives by Takeda to Strengthen Health System for Rare Diseases in India
webmaster
Tuesday, May 23, 2023
to
Best Agrolife Ltd. Receives Patent for Novel Ternary Pesticide Formulation to Combat Major Paddy Pests and Diseases
webmaster
Monday, September 02, 2024